A61P 3/14
For calcium homeostasis
Official title: for calcium homeostasis (vitamin D A61P3/02; parathyroid hormones A61P5/18; calcitonin A61P5/22; osteoporosis A61P19/10; bone metastasis A61P35/04)
A61P3/14 (For calcium homeostasis) appears on 1,441 US grants and 1,775 published applications in this corpus.
Search patents in A61P- Granted patents
- 1,441
- Published applications
- 1,775
- Assignees
- 730
- Inventors
- 3,861
- Latest grant
- 31 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 2 | 0 |
| 1978 | 1 | 0 |
| 1979 | 1 | 0 |
| 1980 | 3 | 0 |
| 1981 | 2 | 0 |
| 1982 | 2 | 0 |
| 1983 | 2 | 0 |
| 1984 | 4 | 0 |
| 1985 | 12 | 0 |
| 1986 | 9 | 0 |
| 1987 | 19 | 0 |
| 1988 | 24 | 0 |
| 1989 | 18 | 0 |
| 1990 | 26 | 0 |
| 1991 | 12 | 0 |
| 1992 | 15 | 0 |
| 1993 | 9 | 0 |
| 1994 | 21 | 0 |
| 1995 | 13 | 0 |
| 1996 | 18 | 0 |
| 1997 | 24 | 0 |
| 1998 | 32 | 0 |
| 1999 | 30 | 0 |
| 2000 | 33 | 0 |
| 2001 | 39 | 14 |
| 2002 | 39 | 50 |
| 2003 | 41 | 113 |
| 2004 | 37 | 105 |
| 2005 | 32 | 112 |
| 2006 | 52 | 94 |
| 2007 | 47 | 104 |
| 2008 | 43 | 92 |
| 2009 | 50 | 146 |
| 2010 | 78 | 151 |
| 2011 | 77 | 102 |
| 2012 | 67 | 113 |
| 2013 | 91 | 75 |
| 2014 | 74 | 106 |
| 2015 | 64 | 65 |
| 2016 | 61 | 54 |
| 2017 | 56 | 51 |
| 2018 | 33 | 39 |
| 2019 | 29 | 38 |
| 2020 | 29 | 37 |
| 2021 | 17 | 27 |
| 2022 | 13 | 20 |
| 2023 | 17 | 23 |
| 2024 | 10 | 20 |
| 2025 | 10 | 17 |
| 2026 | 3 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Choline bolus compositions for ruminants31 Mar 2026US 12,589,084 B2Alberta Veterinary Laboratories Ltd.
- Use of collagen hydrolysate in prevention and/or treatment of food craving31 Mar 2026US 12,589,131 B2Rousselot B.V.
- Use of triazole compound as ghrelin receptor agonist10 Mar 2026US 12,570,617 B2Kyungpook National University Industry-Academic Cooperation Foundation
- TNAP locally administered for promoting periodontal health25 Nov 2025US 12,478,662 B2Ohio State Innovation Foundation
- Methods and compositions for preventing or treating calciphylaxis7 Oct 2025US 12,433,854 B2Epizon Pharma, Inc.
- Treatment of hypoparathyroidism using triphenyl calcilytic compounds1 Oct 2026US 2026/0294857 A1Calcilytix Therapeutics, Inc.
- Necrosis inhibitor30 Jul 2026US 2026/0216141 A1Linkgevity Limited
- Compositions for use in the prophylactic treatment of hypocalcemia in a ruminant animal23 Jul 2026US 2026/0207659 A1Vilofoss A/S
- Compositions and methods using a combination of oleuropein and taurine25 Jun 2026US 2026/0174673 A1Societe des Produits Nestle S. A.
- Probiotic preparation containing akk11 strain for promoting calcium absorption and use thereof23 Apr 2026US 2026/0109939 A1Wecare Probiotics Co., Ltd.
Most cited
By later US patents
- Devices and methods for the restoration of a spinal disc248US 7,004,945 B2SpineWave, Inc. · 2006
- Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same222US 5,359,030 AProtein Delivery, Inc. · 1994
- Albumin fusion proteins comprising GLP-1 polypeptides198US 7,141,547 B2Human Genome Sciences, Inc. · 2006
- Fatty acid treatment169US 5,618,558 AScotia Holdings PLC · 1997
- Substituted alkanediphosphonic acids and pharmaceutical use159US 4,939,130 ACiba-Geigy Corporation · 1990